Ares Management
ARES
$121.66
+3.10%
Ares Management is a leading global alternative asset manager with $622.5 billion in total assets under management, operating across credit, private equity, real estate, and other alternative strategies. As one of the largest players in the alternative asset management industry, Ares distinguishes itself through its scale, diversified platform, and strong track record in private credit. The stock is currently under pressure due to sector-wide concerns about liquidity in private credit markets, as highlighted by recent news of Blue Owl Capital capping redemptions, which has sparked a risk-off move across alternative asset managers. Additionally, the company's exposure to AI infrastructure and private credit has drawn both optimism and skepticism, creating a debate around the sustainability of its growth and fee income.…
ARES
Ares Management
$121.66
Related headlines
Investment Opinion: Should I buy ARES Today?
Rating: Hold. The thesis is that Ares offers a compelling forward valuation (forward P/E 15.98x) and strong revenue growth (40.3% YoY), but near-term risks from private credit liquidity concerns and earnings volatility warrant caution. The analyst consensus is mixed, with Raymond James upgrading to Strong Buy but BMO Capital maintaining Market Perform, reflecting uncertainty.
Supporting Evidence: Revenue grew 40.3% YoY to $1.77 billion in Q4 2025, driven by management fees and carried interest. The forward P/E of 15.98x is below the industry average of 20x, implying a 20% discount. The average analyst EPS estimate of $9.26 suggests a forward P/E of 12.6x at the current price, indicating significant upside if earnings materialize. However, the trailing P/E of 82.5x highlights current earnings weakness, and the net margin collapsed to 3.1% from 14.1%.
Risks & Conditions: The biggest risks are (1) private credit liquidity contagion worsening, (2) failure of earnings to recover to analyst estimates, and (3) high leverage (D/E 3.49) amplifying downside. This Hold would upgrade to Buy if the forward P/E compresses below 12x or if net income shows a clear recovery trend in Q1 2026 earnings. It would downgrade to Sell if the stock breaks below the 52-week low of $95.80 or if another alternative manager announces redemption caps. Valuation verdict: The stock appears undervalued on forward earnings but overvalued on trailing earnings, making it a speculative value play dependent on a turnaround.
Sign up to view all
ARES 12-Month Price Forecast
Ares Management is at a crossroads. The strong revenue growth and massive AUM base provide a solid foundation, but the net income collapse and private credit sector headwinds create significant near-term uncertainty. The forward P/E suggests the market is pricing in a recovery, but the trailing P/E warns of current earnings distress. The neutral stance reflects the balanced risk/reward: the stock could rally 30% if earnings recover, or fall 20% if the private credit crisis worsens. Key developments to watch are Q1 2026 earnings (due in May 2026) and any news on redemption activity in private credit funds. An upgrade to bullish would require net income above $200 million in Q1 2026; a downgrade to bearish would follow a break below $95.80.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ares Management's 12-month outlook, with a consensus price target around $158.16 and implied upside of +30.0% versus the current price.
Average Target
$158.16
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$97 - $158
Analyst target range
Only 2 analysts cover Ares, which is limited for a company of its size, likely due to its complex structure and recent volatility. The consensus recommendation is not explicitly provided, but the average estimated EPS is $9.26, with a low of $8.73 and high of $9.99. The average revenue estimate is $11.81 billion, with a range of $11.29 billion to $12.52 billion. Based on the current price of $116.90 and the average EPS estimate of $9.26, the implied forward P/E is 12.6x, which is below the forward P/E of 15.98x from valuation data, suggesting potential upside if earnings materialize. However, without explicit price targets, the implied upside/downside cannot be calculated. The limited coverage means that the stock may be less efficiently priced, and investors should be cautious about relying on consensus estimates. The recent institutional ratings show a mix of bullish and neutral stances: Raymond James upgraded to Strong Buy in February 2026, while BMO Capital maintained Market Perform. This divergence reflects uncertainty about the company's near-term prospects amid the private credit turmoil.
Bulls vs Bears: ARES Investment Factors
Ares Management presents a high-conviction but high-risk opportunity. The bull case rests on strong revenue growth (40.3% YoY), a massive AUM base, and a forward P/E (15.98x) that discounts a dramatic earnings recovery. The bear case centers on a 69% net income collapse, sector-wide private credit liquidity fears, and extreme leverage (D/E 3.49). The single most important tension is whether the earnings recovery implied by the forward P/E materializes: if net income rebounds to analyst estimates of $9.26 EPS, the stock is deeply undervalued; if the private credit turmoil persists and earnings remain depressed, the trailing P/E of 82.5x suggests severe overvaluation. Currently, the bearish evidence from the price action and sector news is stronger, but the valuation on forward earnings offers a compelling entry for patient investors.
Bullish
- Strong Revenue Growth: Revenue surged 40.3% YoY in Q4 2025 to $1.77 billion, driven by management fees ($1.01B) and carried interest ($217M). This reflects robust AUM expansion and strong investment performance across credit and private equity.
- Forward P/E Discount to Peers: The forward P/E of 15.98x is below the asset management industry average of ~20x, implying a 20% discount. If earnings normalize as analysts expect, the stock offers compelling value relative to peers.
- Massive AUM Base Generates Fees: With $622.5 billion in total AUM and $384.9 billion in fee-earning AUM, Ares generates substantial recurring management fees. The credit segment alone ($406.9B AUM) provides a stable revenue base.
- Analyst Upgrade Signals Confidence: Raymond James upgraded ARES to Strong Buy in February 2026, indicating institutional conviction despite sector headwinds. The average EPS estimate of $9.26 implies a forward P/E of just 12.6x at the current price.
Bearish
- Net Income Collapse in Q4 2025: Net income plunged to $54.2 million in Q4 2025 from $177.3 million a year ago, a 69% decline. The net margin fell to 3.1% from 14.1%, driven by a spike in other expenses ($765.7M vs $9.9M) and high interest costs.
- Private Credit Liquidity Contagion: Blue Owl Capital's decision to cap redemptions in April 2026 sparked a sector-wide panic, hitting alternative asset managers. ARES stock fell 34.3% over the past year, reflecting fears of liquidity stress in private credit funds.
- Extreme Leverage and Debt Risk: Debt-to-equity ratio of 3.49 is elevated for an asset manager, amplifying financial risk. Interest expense of $186.1 million in Q4 2025 consumed a significant portion of operating income, pressuring earnings.
- Negative Free Cash Flow in Q4: Free cash flow was -$2.15 billion in Q4 2025 due to large investment purchases ($8.5B) and debt repayments. While TTM FCF is positive at $1.54B, the quarterly volatility raises concerns about cash flow stability.
ARES Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -34.3% and currently trading at 59.9% of its 52-week range ($95.80 low to $195.26 high). The price sits at $116.90, well below the midpoint of the range, indicating persistent selling pressure and bearish sentiment. The stock's beta of 1.536 confirms it is 53.6% more volatile than the market, amplifying both downside and upside moves. Short-term momentum shows a mixed picture: the 1-month change is -8.9%, while the 3-month change is +14.1%, suggesting a short-term recovery from the March lows near $96.50. However, the 1-year downtrend remains intact, and the recent 1-month decline indicates renewed weakness after the April-May bounce. The divergence between the 3-month gain and 1-month loss could signal a failed rally or a consolidation phase before a potential trend reversal. The 52-week low at $95.80 serves as critical support; a breakdown below this level would signal further downside, potentially targeting the March 2026 low of $96.50. Resistance is at the 52-week high of $195.26, and a breakout above that would require a 67% rally, which seems unlikely given the current headwinds. The stock's high beta means it is likely to amplify any market moves, and the recent sector-wide panic in private credit adds to the risk of further declines.
Beta
1.54
1.54x market volatility
Max Drawdown
-49.9%
Largest decline past year
52-Week Range
$96-$195
Price range past year
Annual Return
-31.3%
Cumulative gain past year
| Period | ARES Return | S&P 500 |
|---|---|---|
| 1m | -6.9% | +2.0% |
| 3m | +21.1% | +10.6% |
| 6m | -30.8% | +8.3% |
| 1y | -31.3% | +20.4% |
| ytd | -26.9% | +10.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARES Fundamental Analysis
Revenue has been growing strongly, with the most recent quarter (Q4 2025) reporting $1.77 billion, up 40.3% year-over-year from $1.26 billion in Q4 2024. This growth is driven by management fees ($1.01 billion) and carried interest ($217 million), reflecting AUM expansion and strong investment performance. However, net income in Q4 2025 was only $54.2 million, a sharp decline from $177.3 million in Q4 2024, due to a significant increase in other expenses ($765.7 million vs. $9.9 million) and interest expense ($186.1 million vs. $246.6 million). The net margin fell to 3.1% from 14.1% a year ago, indicating that revenue growth is not translating to bottom-line profitability. Gross margin remains high at 72.6%, but operating margin dropped to 29.3% from 22.1% in Q4 2024, suggesting cost pressures. The company's balance sheet shows a debt-to-equity ratio of 3.49, which is elevated for an asset manager, and a current ratio of 2.24, indicating adequate short-term liquidity. Free cash flow was negative -$2.15 billion in Q4 2025, largely due to large investment purchases ($8.5 billion) and debt repayments ($445 million), but trailing twelve-month free cash flow is $1.54 billion, showing that the company can generate cash over a longer horizon. ROE is 12.3%, which is reasonable but below historical highs, and the high leverage (debt/equity 3.49) increases financial risk.
Quarterly Revenue
$1.8B
2025-12
Revenue YoY Growth
+40.25%
YoY Comparison
Gross Margin
72.65%
Latest Quarter
Free Cash Flow
$1.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARES Overvalued?
Since net income is positive (TTM net income of $527 million), the primary valuation metric is the P/E ratio. The trailing P/E is 82.5x, while the forward P/E is 15.98x, implying that the market expects a dramatic earnings recovery. This gap is unusually wide and suggests that current earnings are depressed by non-recurring items, and analysts expect normalized earnings to be much higher. Compared to the asset management industry average P/E of approximately 20x, Ares trades at a 310% premium on a trailing basis but a 20% discount on a forward basis. The forward discount may be justified if the company can achieve the expected earnings rebound, but the trailing premium highlights the current earnings weakness. Historically, Ares' trailing P/E has ranged from 25x to 165x over the past five years. The current 82.5x is near the middle of that range, but the forward P/E of 15.98x is near the lower end, suggesting that the market is pricing in a normalization of earnings. The P/S ratio of 5.43x is below the industry average of 6.5x, indicating that the stock is cheaper on a sales basis, but this is less relevant given positive earnings.
PE
82.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -77x~165x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
28.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Ares' net income collapsed 69% YoY in Q4 2025 to $54.2 million, with net margin falling to 3.1% from 14.1%. The primary culprit was a surge in other expenses to $765.7 million from $9.9 million, which appears non-recurring but highlights earnings volatility. The debt-to-equity ratio of 3.49 is high for an asset manager, and interest expense of $186.1 million in Q4 2025 consumed 36% of operating income. Negative free cash flow of -$2.15 billion in Q4 2025, driven by $8.5 billion in investment purchases, raises liquidity concerns despite a current ratio of 2.24.
Market & Competitive Risks: The stock's beta of 1.536 makes it 53.6% more volatile than the market, amplifying downside during sector selloffs. The private credit liquidity panic triggered by Blue Owl Capital's redemption cap in April 2026 has caused a risk-off move across alternative asset managers, with ARES falling 34.3% over the past year. The stock trades at only 59.9% of its 52-week range, indicating persistent bearish sentiment. Limited analyst coverage (only 2 analysts) means less efficient pricing and potential for sharp moves on news.
Worst-Case Scenario: A deepening private credit crisis could trigger a wave of redemption requests across the industry, forcing Ares to liquidate assets at distressed prices. This would compress fee income, trigger further earnings declines, and potentially force dividend cuts. The 52-week low of $95.80 represents a 18% downside from the current price of $116.90. In a severe scenario mirroring the March 2026 low of $96.50, an investor could lose approximately 17.5%. The historical max drawdown of -49.94% suggests that in a worst-case recession, the stock could fall to around $58.50, representing a 50% loss from current levels.
FAQ
The primary risk is private credit liquidity contagion, as evidenced by Blue Owl Capital's redemption cap in April 2026, which could spread to Ares and trigger asset sales. Financial risk is elevated with a debt-to-equity ratio of 3.49 and net income that fell 69% YoY in Q4 2025. Market risk is high due to a beta of 1.536, meaning the stock is 53.6% more volatile than the S&P 500. Company-specific risk includes limited analyst coverage (only 2 analysts), which can lead to inefficient pricing and sharp moves on news. The most severe risk is a worst-case scenario where the stock falls to its 52-week low of $95.80 or below, representing an 18%+ loss from the current price.
The 12-month outlook is balanced across three scenarios. The base case (50% probability) sees the stock trading in a $110-$140 range as earnings gradually improve but remain below historical highs. The bull case (25% probability) targets $150-$180 if private credit fears subside and net income recovers sharply. The bear case (25% probability) sees the stock falling to $80-$100 if the private credit crisis deepens. The most likely scenario is the base case, assuming earnings normalize but sector headwinds persist. Key catalysts include the next earnings report and any industry news on private credit liquidity.
ARES is a tale of two valuations. On a trailing basis, the P/E of 82.5x is extremely high, reflecting depressed net income of $527 million TTM. On a forward basis, the P/E of 15.98x is below the industry average of 20x, implying the stock is undervalued if analysts' EPS estimate of $9.26 is achieved. The P/S ratio of 5.43x is below the industry average of 6.5x, further supporting the undervaluation case on a sales basis. However, the wide gap between trailing and forward P/E indicates that the market is pricing in a dramatic earnings recovery, which is uncertain. Overall, the stock appears undervalued on forward metrics but overvalued on trailing earnings, making it a speculative value play.
ARES presents a high-risk, high-reward opportunity. The stock is down 34.3% over the past year and trades at a forward P/E of 15.98x, which is below the asset management industry average of 20x, suggesting potential value if earnings recover. However, the trailing P/E of 82.5x highlights current earnings weakness, and the private credit sector faces liquidity concerns that could worsen. For risk-tolerant investors with a 12-24 month horizon, ARES could be a good buy if you believe the earnings recovery will materialize. Conservative investors should wait for clearer signs of net income improvement or a break above the 50-day moving average.
ARES is better suited for medium-to-long-term investment (12-24 months) given its high volatility (beta 1.536) and the uncertain near-term outlook. Short-term trading is risky due to the stock's 34.3% decline over the past year and sensitivity to sector news. The dividend yield of 5.0% provides some income for long-term holders, but the payout ratio of 333% indicates the dividend may not be sustainable if earnings don't recover. A minimum holding period of 12 months is recommended to allow time for the earnings recovery thesis to play out. The stock is not suitable for conservative investors or those needing short-term liquidity.